Breaking News & Top Stories
Recent evaluations commissioned by the World Health Organization have confirmed that glucagon-like peptide-1 (GLP-1) receptor agonists, including tirzepatide (marketed as Mounjaro and Zepbound), semaglutide (available as Ozempic and Wegovy), and…
The US Food and Drug Administration (FDA) has instructed drug manufacturers Novo Nordisk and Eli Lilly to eliminate warnings regarding potential suicidal thoughts and behaviors from their widely used weight-loss…
Arrowhead Pharmaceuticals announced promising early results from its gene-silencing drug, ARO-INHBE, which has demonstrated significant weight loss effects in individuals with obesity. In a Phase 1/2 study, patients receiving two…
Viewers of *World News Tonight* with David Muir were surprised this week as the anchor detailed a new agreement between the administration of former President Donald Trump and two major…